Cationic micellar nanoparticles for DNA and doxorubicin co-delivery

Area of Science:

• Biomaterials Science
• Nanotechnology
• Drug Delivery Systems
• Gene Therapy

Background:

• Developing effective co-delivery systems for both therapeutic genes and chemotherapeutic drugs is crucial for enhancing cancer treatment efficacy.
• Cationic polymers and nanoparticles offer potential for nucleic acid complexation and cellular uptake, but often face challenges with cytotoxicity and stability.
• Block copolymers provide a versatile platform for creating complex nanostructures with tailored properties for drug and gene delivery.

Purpose of the Study:

• To synthesize and characterize a novel poly-(N-ε-carbobenzyloxy-l-lysine) (PZLL) and dendritic polyamidoamine (PAMAM) block copolymer (PZLL-D3) for nanoparticle formulation.
• To evaluate the potential of PZLL-D3 based micellar nanoparticles for the co-delivery of therapeutic plasmid DNA (pDNA) and doxorubicin (DOX).
• To assess the in vitro performance, including cytotoxicity, pDNA complexation, protection, transfection efficiency, and drug release kinetics.

Main Methods:

• Synthesis of PZLL-D3 block copolymer via copper-catalyzed azide alkyne cyclization (click) reaction.
• Characterization of the copolymer structure using (1)H NMR and FTIR, and determination of buffering capability via acid-base titration.
• In vitro evaluation using MTT assays, agarose gel electrophoresis, flow cytometry, and drug release studies at different pH values.

Main Results:

• PZLL-D3 copolymer successfully formed cationic micellar nanoparticles capable of co-delivering pDNA and doxorubicin (DOX).
• The nanoparticles exhibited low in vitro cytotoxicity, strong pDNA condensation, effective protection against deoxyribonuclease I degradation, and high gene transfection efficiency in 293T and HeLa cells.
• Sustained in vitro release of DOX from the loaded nanoparticles was observed at both pH 7.4 and pH 5.8, indicating potential for tumor microenvironment responsiveness.

Conclusions:

• The synthesized PZLL-D3 block copolymer is a promising material for developing cationic micellar nanoparticles for dual gene and chemotherapeutic agent co-delivery.
• These nanoparticles demonstrate favorable characteristics for gene therapy and targeted cancer treatment, including efficient delivery, protection of genetic material, and controlled drug release.
• The findings support the potential of PZLL-D3 based nanocarriers as a viable strategy for improving the efficacy of combination cancer therapies.